236 related articles for article (PubMed ID: 16106399)
1. Macrophage migration and gene expression in response to tumor hypoxia.
Murdoch C; Lewis CE
Int J Cancer; 2005 Dec; 117(5):701-8. PubMed ID: 16106399
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues.
Murdoch C; Giannoudis A; Lewis CE
Blood; 2004 Oct; 104(8):2224-34. PubMed ID: 15231578
[TBL] [Abstract][Full Text] [Related]
3. Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies.
Lewis C; Murdoch C
Am J Pathol; 2005 Sep; 167(3):627-35. PubMed ID: 16127144
[TBL] [Abstract][Full Text] [Related]
4. Monocytes and dendritic cells in a hypoxic environment: Spotlights on chemotaxis and migration.
Bosco MC; Puppo M; Blengio F; Fraone T; Cappello P; Giovarelli M; Varesio L
Immunobiology; 2008; 213(9-10):733-49. PubMed ID: 18926289
[TBL] [Abstract][Full Text] [Related]
5. Expression of HIF-1alpha by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy.
Burke B; Tang N; Corke KP; Tazzyman D; Ameri K; Wells M; Lewis CE
J Pathol; 2002 Feb; 196(2):204-12. PubMed ID: 11793372
[TBL] [Abstract][Full Text] [Related]
6. Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors.
Kes MMG; Van den Bossche J; Griffioen AW; Huijbers EJM
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188427. PubMed ID: 32961257
[TBL] [Abstract][Full Text] [Related]
7. Mathematical modeling predicts synergistic antitumor effects of combining a macrophage-based, hypoxia-targeted gene therapy with chemotherapy.
Owen MR; Stamper IJ; Muthana M; Richardson GW; Dobson J; Lewis CE; Byrne HM
Cancer Res; 2011 Apr; 71(8):2826-37. PubMed ID: 21363914
[TBL] [Abstract][Full Text] [Related]
8. Achieving hypoxia-inducible gene expression in tumors.
Marignol L; Lawler M; Coffey M; Hollywood D
Cancer Biol Ther; 2005 Apr; 4(4):359-64. PubMed ID: 15846086
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible lentiviral gene expression in engineered human macrophages.
Chinn HK; Gardell JL; Matsumoto LR; Labadie KP; Mihailovic TN; Lieberman NAP; Davis A; Pillarisetty VG; Crane CA
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35728871
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR.
Guo X; Xue H; Shao Q; Wang J; Guo X; Chen X; Zhang J; Xu S; Li T; Zhang P; Gao X; Qiu W; Liu Q; Li G
Oncotarget; 2016 Dec; 7(49):80521-80542. PubMed ID: 27602954
[TBL] [Abstract][Full Text] [Related]
11. Effects of hypoxia on transcription factor expression in human monocytes and macrophages.
Elbarghati L; Murdoch C; Lewis CE
Immunobiology; 2008; 213(9-10):899-908. PubMed ID: 18926304
[TBL] [Abstract][Full Text] [Related]
12. Targeting gene therapy to cancer: a review.
Dachs GU; Dougherty GJ; Stratford IJ; Chaplin DJ
Oncol Res; 1997; 9(6-7):313-25. PubMed ID: 9406237
[TBL] [Abstract][Full Text] [Related]
13. How to overcome (and exploit) tumor hypoxia for targeted gene therapy.
Greco O; Marples B; Joiner MC; Scott SD
J Cell Physiol; 2003 Dec; 197(3):312-25. PubMed ID: 14566961
[TBL] [Abstract][Full Text] [Related]
14. Exploiting the cancer niche: Tumor-associated macrophages and hypoxia as promising synergistic targets for nano-based therapy.
Silva VL; Al-Jamal WT
J Control Release; 2017 May; 253():82-96. PubMed ID: 28285930
[TBL] [Abstract][Full Text] [Related]
15. Macrophages and the hypoxic tumour microenvironment.
Knowles HJ; Harris AL
Front Biosci; 2007 May; 12():4298-314. PubMed ID: 17485376
[TBL] [Abstract][Full Text] [Related]
16. IL10, IL11, IL18 are differently expressed in CD14+ TAMs and play different role in regulating the invasion of gastric cancer cells under hypoxia.
Shen Z; Seppänen H; Vainionpää S; Ye Y; Wang S; Mustonen H; Puolakkainen P
Cytokine; 2012 Aug; 59(2):352-7. PubMed ID: 22595646
[TBL] [Abstract][Full Text] [Related]
17. Cancer-inducible transgene expression by the Grp94 promoter: spontaneous activation in tumors of various origins and cancer-associated macrophages.
Reddy RK; Dubeau L; Kleiner H; Parr T; Nichols P; Ko B; Dong D; Ko H; Mao C; DiGiovanni J; Lee AS
Cancer Res; 2002 Dec; 62(24):7207-12. PubMed ID: 12499260
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia inhibits macrophage migration.
Turner L; Scotton C; Negus R; Balkwill F
Eur J Immunol; 1999 Jul; 29(7):2280-7. PubMed ID: 10427991
[TBL] [Abstract][Full Text] [Related]
19. Luteolin inhibits angiogenesis of the M2‑like TAMs via the downregulation of hypoxia inducible factor‑1α and the STAT3 signalling pathway under hypoxia.
Fang B; Chen X; Wu M; Kong H; Chu G; Zhou Z; Zhang C; Chen B
Mol Med Rep; 2018 Sep; 18(3):2914-2922. PubMed ID: 30015852
[TBL] [Abstract][Full Text] [Related]
20. An HRE-Binding Py-Im Polyamide Impairs Hypoxic Signaling in Tumors.
Szablowski JO; Raskatov JA; Dervan PB
Mol Cancer Ther; 2016 Apr; 15(4):608-17. PubMed ID: 26719577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
